For citations:
Krysanov I.S., Makarova E.V., Ermakova V.Yu., Kurkin D.V., Kolosov Yu.A., Vaskova L.B. Clinical and economic assessment of an extended release lanreotide formulation (Somatuline® Autogel®) in patients with gastrointestinal neuroendocrine tumors. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025;18(4):483-492. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.348
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 